Virtual CFO for pharma and life sciences
Rising revenue should not mean falling margins.
For pharma manufacturers, distributors and life sciences companies. We bring product-wise profitability, distributor margin control and the compliance discipline a regulated business needs.
What we see in pharma businesses
Problems we fix every month
Revenue growing, margins falling
Without a product-wise P&L, the products that drive volume can be the ones that erode margin.
Distributor pricing and credit out of control
Discounts, credit terms and returns vary across distributors and stockists, with little visibility.
Batch and product costing that lags
Raw material, packaging and conversion costs move, but standard costs are rarely updated.
Inventory with expiry risk
Slow-moving and near-expiry stock ties up cash and ends in write-offs.
Costs rising with no root cause
Costs grow across departments without cost-centre budgets or variance tracking.
A heavy compliance load
Licences, GST, PF, ESIC and Companies Act compliance need a dependable calendar.
Product and SKU-wise profitability
Built from scratch where needed, so every product carries its true cost.
Distributor margin analysis
Margins, credit and returns by distributor, with renegotiation support where the numbers justify it.
Cost-centre budgets
Budgets by department, with monthly variance tracking and owners.
Inventory and expiry tracking
Ageing and expiry visibility, so stock is cleared before it becomes a write-off.
Compliance calendar
Every statutory filing tracked and delivered on time.
Client impact
What this looks like in practice
Business names are withheld for confidentiality. The outcomes are from actual engagements.
4 to 6%
Pharma manufacturer: margin recovered
Revenue was growing while margins fell. We built SKU-wise profitability from scratch, renegotiated distributor margins and set cost-centre budgets with variance tracking.
Unprofitable SKUs were identified and repriced, cost leakages were plugged, and the owner moved from gut-feel to data-led growth decisions.
You deal with the principal, not a junior.
Amit Tiwary
Founder-Director, ProCFO
Amit has spent 20+ years in corporate finance and advisory, and has guided 100+ businesses through fundraising, CFO services, operational finance and M&A. He leads every ProCFO engagement personally, backed by a multi-qualified team of accountants, company secretaries and analysts, with maker-checker review on every deliverable.
He is a Chartered Accountant, Cost and Management Accountant and Company Secretary, with an Advanced Diploma in Management Accounting from CIMA, London.
How we can help
Services that fit pharma businesses
Managed CFO Office
Your entire finance department as a service, from daily books to the board pack. See the tiers
CFO Services
Planning, MIS, profitability, cash and working capital, led by a senior CFO. Learn more
Specialist Advisory
Valuation, ESOPs, pricing, projections and finance SOPs. Learn more
FAQ
Frequently asked questions
Can you build product and batch-level costing?
Yes. We build costing that reflects raw material, packaging, conversion and regulatory costs, and keep it updated as prices move.
Can you help with distributor renegotiation?
Yes. We analyse margins, credit and returns by distributor and support renegotiation with the numbers behind it.
Do you work with life sciences startups as well as manufacturers?
Yes. Earlier-stage companies get budgeting, burn and runway tracking and fundraising readiness. Manufacturers get product profitability and cost control.
How do you handle near-expiry inventory?
We set up inventory ageing and expiry tracking, flag risk early, and work with your team on clearance before stock turns into a write-off.
Your next step
Get your margins back under control.
One conversation will show you which products, distributors and costs to look at first.
+91 97314 05575
info@procfo.co.in